Growth

AMCP Nexus held its annual meeting on October 16-19, 2023 in Orlando, FL, with over 3000 attendees involved in managed care and market access. Lockwood’s market access leadership attended the conference to engage in educational sessions and connect with both clients and managed care decision-makers. Lockwood Market Access served as a sponsor again, this time sponsoring the Dog Park and bringing a much-needed puppy break to a week of sessions and meetings, highlighting some of the hot topics in the industry ranging from the impact of the IRA to redefining value assessments. These trends were summarized in a Top Trends review following the meeting.

The Inaugural meeting of the ISMPP Academy took place in Philadelphia from Sept 28-29, 2023.

The meeting theme was PREP (Practical Resources to Elevate Publications).

Our own head of publication services, Steve Palmisano, followed the keynote presentation by co-presenting a talk titled, “Progress to Practice: Navigating the Non-negotiables”.

The talk focused on the tremendous progress the medical publication profession has made over the past 20 years, including the development of several guidelines and codes of practice (see figure below) that shape much of the compliance-related ‘non-negotiables” we have in our profession today.

For this inaugural meeting, there were more than 170 attendees. With excellent presentations covering extending the reach with publication extenders, going beyond the traditional publication plans, and a major session that closed the meeting, “AI’s Transformative Impact on Medicla Communications”.

Following attendance at the meeting, The Lockwood Group summarized it’s meeting notes into the Top 10 Take-aways.

This month, we are proudly celebrating our first anniversary welcoming Random42, a best-in-class medical animation studio, to the Lockwood Group. Over the past year, our affiliation has elevated the work and capabilities of both companies, combining Lockwood’s scientific-based medical, publications, and market access communications with Random42’s animated scientific storytelling.

In addition to over 140 amazing new team members, Random42 brings a range of innovative digital capabilities such as medical animation, virtual reality, augmented reality, and interactive microsites to the Lockwood Group, and as an extension—to our clients.

“We've had a tremendous year since Random42 joined us and are excited to celebrate our first year together. With the Random42 partnership, we’re now able to offer our clients a more integrated suite of services that satisfy a larger portion of our clients’ requests. Whether it’s an MOA, MOD, microsite, AR, VR, or a hologram for an upcoming conference, Random42 is the market leader, and we’re excited to leverage that expertise for our clients.” said Lockwood CEO and Founder, Matthew Schecter.

From the very beginning, Random42's shared commitment to quality and culture captivated us. As our growth continues, these values remain at the foundation of our strategy moving forward.

“Although it doesn’t feel like a year, the synergies between Random42 and Lockwood seem to be growing all the time – highlighting the huge potential for the group’s continued growth.” said Random42 CEO, Ben Ramsbottom. “Many positive steps have been made at Random42, with investments seen in people, IT infrastructure and technology, all supported by Matt and the team at Lockwood. These changes have been implemented to enhance the business, but not to change it, maintaining company culture, and our strong identity. I am so pleased that we have found a partner who understands our business and sees how we can change the medical communication landscape together.”

As we celebrate this significant milestone, we reflect on all that we’ve accomplished during our first year together and look forward to our continued collaboration and growth. We are excited to introduce clients to a partnership where science, creativity, and strategy come to life, and make a lasting impact to the pharmaceutical and biotech industries.

Excited to share an interview featuring our Founder & CEO, Matt Schecter, with Houlihan Lokey’s Managing Director, Mark Martin, for their inaugural Thought Leader Interview Series. They discussed our company’s engagement with HCPs during the pre-approval process, the impact of FDA approval slowdowns, the evolution of the industry landscape, and more. Click here to read the interview.

Our entire company was live and in person at the Mohegan Sun in Connecticut for our annual Year Beginning Meeting (YBM). Each year, we come together to learn, reconnect, and recognize each other’s success and accomplishments. In the spirit of this year’s theme, Better Together, many of our sessions were centered around the power of working as a team and embracing our people-first mentality. We celebrated Martin Luther King Jr. Day together with a day of service, assembling over 100 care packages for our troops overseas. We couldn't be more grateful to kick-off another year with such an amazing group of people!

As the year comes to an end, we are humbled to reflect on the amazing year we've had with our clients and team members. Thank you to all who made 2022 such a great year!

Check out the latest addition to The Lockwood Group, Random42.

Where the world of science, art, and technology intertwine, we are thrilled to bring our clients new best-in-class, innovative, capabilities.

We are thrilled to announce the expansion of The Lockwood Group, with a strategic investment in Random42 Scientific Communication, a best-in-class medical animation studio based in London, England. Please join us in welcoming Random42 to the Lockwood Family! 

We are excited to be named one of the Financial Times Americas' Fastest Growing Companies for a third consecutive year! This prestigious award honors 500 outstanding companies among the millions of North and South American enterprises, and we are humbled to continue to be one of them!